Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial

Publication date: June 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 6Author(s): Ronnie Aronson, Aihua Li, Ruth E Brown, Sarah McGaugh, Michael C Riddell
Source: The Lancet Diabetes and Endocrinology - Category: Endocrinology Source Type: research